Literature DB >> 1541535

Partial characterization and staphylocidal activity of thrombin-induced platelet microbicidal protein.

M R Yeaman1, S M Puentes, D C Norman, A S Bayer.   

Abstract

Thrombin-induced platelet microbicidal protein (PMP) is considered to play an important role in preventing an important role in preventing streptococcal endocarditis. However, the structural features and functions of PMPs have not been well characterized, and their antibacterial spectra against other common endocarditis pathogens, such as the staphylococci, are not known. Thrombin stimulation of washed rabbit platelets (10(8)/ml) yielded a PMP-rich preparation with a specific activity of approximately 25 U/mg of protein as determined by Bacillus subtilis bioassay. Twenty-eight clinical and laboratory Staphylococcus aureus isolates, exposed to a standardized PMP preparation (100 U/ml for 2 h at 37 degrees C), exhibited a Poisson-distributed heterogeneity to the bactericidal action of PMP, with approximately one-third designated as PMP resistant. Gel filtration chromatography (Sephadex G-50) identified the bioactive moiety within PMP preparations to be in the major protein elution peak; sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) presumptively identified PMP as a low-molecular-weight (MW) (8,500) protein present only in such bioactive protein peaks. Both the bioactivity of PMP preparations and the low-MW protein band were removable by specific anionic membranes (e.g., cellulose-acetate/nitrate), as well as by a variety of anionic resins, further corroborating the suspected cationic charge of PMP. In addition, both PMP bioactivity and the low-MW protein band were recoverable by 1.5 M NaCl elution of the anionic membrane filters post-PMP adsorptive removal. Adsorption of bioactive PMP preparations by highly PMP-susceptible B. subtilis (10(8) CFU/ml, 30 min) resulted in a near-complete loss of residual bioactivity; in contrast, adsorption of bioactive PMP preparations with less PMP-susceptible S. aureus strains failed to reduce bioactivity. Significant lysozyme contamination of PMP-rich preparations was ruled out by determination of differences between bioactive PMP preparations and exogenous lysozyme as regards (i) relative heat stabilities; (ii) differential bactericidal activity versus B. subtilis and Micrococcus luteus; and (iii) SDS-PAGE protein profiles. These data show that the bioactive PMP protein moiety is of low MW, is heat stable, is probably cationic (similar to leukocyte-derived defensins), and possesses potent bactericidal activity against a significant percentage of S. aureus isolates.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1541535      PMCID: PMC257613          DOI: 10.1128/iai.60.3.1202-1209.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Experimental bacterial endocarditis. IV. Structure and evolution of very early lesions.

Authors:  D T Durack
Journal:  J Pathol       Date:  1975-02       Impact factor: 7.996

2.  Experimental bacterial endocarditis. II. Survival of a bacteria in endocardial vegetations.

Authors:  D T Durack; P B Beeson
Journal:  Br J Exp Pathol       Date:  1972-02

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Defensins.

Authors:  T Ganz; M E Selsted; R I Lehrer
Journal:  Eur J Haematol       Date:  1990-01       Impact factor: 2.997

Review 5.  beta-Lysin of platelet origin.

Authors:  D M Donaldson; J G Tew
Journal:  Bacteriol Rev       Date:  1977-06

6.  Procoagulant activity of endocardial vegetations and blood monocytes in rabbits with Streptococcus sanguis endocarditis.

Authors:  A G Buiting; J Thompson; D van der Keur; W C Schmal-Bauer; R M Bertina
Journal:  Thromb Haemost       Date:  1989-11-24       Impact factor: 5.249

7.  Purification and antibacterial activity of antimicrobial peptides of rabbit granulocytes.

Authors:  M E Selsted; D Szklarek; R I Lehrer
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

8.  Antibacterial peptide from normal rabbit serum. 3. Inhibition of microbial electron transport.

Authors:  S F Carroll; R J Martinez
Journal:  Biochemistry       Date:  1981-10-13       Impact factor: 3.162

9.  Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels.

Authors:  P J Hitchcock; T M Brown
Journal:  J Bacteriol       Date:  1983-04       Impact factor: 3.490

10.  Comparative bactericidal activities of blood serum and plasma serum.

Authors:  J G HIRSCH
Journal:  J Exp Med       Date:  1960-07-01       Impact factor: 14.307

View more
  63 in total

1.  Thrombin-induced platelet microbicidal protein susceptibility phenotype influences the outcome of oxacillin prophylaxis and therapy of experimental Staphylococcus aureus endocarditis.

Authors:  V K Dhawan; A S Bayer; M R Yeaman
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

2.  A liaR deletion restores susceptibility to daptomycin and antimicrobial peptides in multidrug-resistant Enterococcus faecalis.

Authors:  Jinnethe Reyes; Diana Panesso; Truc T Tran; Nagendra N Mishra; Melissa R Cruz; Jose M Munita; Kavindra V Singh; Michael R Yeaman; Barbara E Murray; Yousif Shamoo; Danielle Garsin; Arnold S Bayer; Cesar A Arias
Journal:  J Infect Dis       Date:  2014-10-31       Impact factor: 5.226

3.  In vitro antibacterial activities of platelet microbicidal protein and neutrophil defensin against Staphylococcus aureus are influenced by antibiotics differing in mechanism of action.

Authors:  Y Q Xiong; M R Yeaman; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

4.  Membrane permeabilization by thrombin-induced platelet microbicidal protein 1 is modulated by transmembrane voltage polarity and magnitude.

Authors:  S P Koo; A S Bayer; B L Kagan; M R Yeaman
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

5.  Staphylococcus aureus, Platelets, and the Heart.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

6.  Diminished virulence of a sar-/agr- mutant of Staphylococcus aureus in the rabbit model of endocarditis.

Authors:  A L Cheung; K J Eberhardt; E Chung; M R Yeaman; P M Sullam; M Ramos; A S Bayer
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

7.  Platelet microbicidal protein alone and in combination with antibiotics reduces Staphylococcus aureus adherence to platelets in vitro.

Authors:  M R Yeaman; P M Sullam; P F Dazin; A S Bayer
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  In vitro resistance to platelet microbicidal protein correlates with endocarditis source among bacteremic staphylococcal and streptococcal isolates.

Authors:  T Wu; M R Yeaman; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

9.  Factors influencing time to vancomycin-induced clearance of nonendocarditis methicillin-resistant Staphylococcus aureus bacteremia: role of platelet microbicidal protein killing and agr genotypes.

Authors:  Pamela A Moise; Alan Forrest; Arnold S Bayer; Yan Q Xiong; Michael R Yeaman; George Sakoulas
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

10.  Platelets and Platelet Inhibitors in Infective Endocarditis.

Authors:  Bruno Hoen
Journal:  Curr Infect Dis Rep       Date:  2002-08       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.